Is Cigna Group Stock Underperforming the Dow?

Core Insights - The Cigna Group is a diversified health services leader that integrates insurance with care solutions, offering a range of services including pharmacy benefit management and Medicare plans [1] Group 1: Company Overview - Cigna has a market capitalization of nearly $76 billion, placing it in the large-cap category, which enhances its negotiating power and investment flexibility [2] - The company operates through its Evernorth and Cigna Healthcare platforms, providing various health services [1] Group 2: Stock Performance - Cigna's shares are currently trading 17.5% below their 52-week high of $350, reached in May 2025, but have increased by 3.8% over the past three months [3] - Over the last 52 weeks, Cigna's stock has declined by 5.4%, underperforming the Dow Jones, which advanced nearly 14% during the same period [6] - Year-to-date in 2026, Cigna's stock has gained 4.9%, outperforming the Dow's 3% rise [6] Group 3: Technical Analysis - Cigna's stock reclaimed its 50-day moving average of $279.40 in late December 2025, indicating improved near-term momentum, although it remains below the 200-day moving average of $291.33 [7] Group 4: Financial Performance - In the fourth quarter of fiscal 2025, Cigna reported a revenue increase of 10.4% year-over-year to $72.5 billion, exceeding analyst expectations of $69.9 billion [8] - Adjusted EPS grew by 21.7% to $8.08, surpassing the consensus estimate of $7.88 [8] - The strong performance was attributed to growth in EverNorth specialty services, successful biosimilar adoption, and operational discipline [9]